Private capital holds a key to enabling value-based healthcare
As parts of the US healthcare industry transition to value-based care, patients should expect better medicine and, hopefully, lower costs. But executing that sprawling and ambitious transition well requires massive up-front investment.
One solution: Value-based care enablement, a business model that groups independent practices or health systems together and takes on the downside risk of the new billing framework. Our latest Industry Research analyst note, The Value-Based Care Enabler Landscape, goes deep on the public and VC- and PE-backed companies driving the shift toward better value healthcare.
Table of contents
| Executive Summary | 1 |
| Introduction | 2 |
| Evaluating VBC enablers | 2 |
| Enablers at the center of the VBC transition | 3 |
| Competitive outlook | 4 |
| VC- and PE-backed enablers | 7 |
| Aledade | 7 |
| Equality Health | 7 |
| Pearl | 8 |
| UpStream Health | 9 |
| Vytalize | 10 |
| Wellvana | 11 |
| Publicly traded enablers | 12 |
| agilon | 12 |
| ApolloMed | 12 |
| CareMax | 13 |
| P3 Health Partners | 13 |
| Privia | 14 |